Skip to main content
Mark Faries, MD, General Surgery, Los Angeles, CA

MarkBFariesMD

General Surgery Los Angeles, CA

Melanoma, Surgical Oncology (Other than Breast)

The Angeles Clinic and Research Institute / Cedars Sinai

Dr. Faries is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Faries' full profile

Already have an account?

  • Office

    11800 Wilshire Blvd
    Fl 3
    Los Angeles, CA 90025
    Phone+1 310-967-1884
    Fax+1 310-967-1744

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Surgery, 1995 - 2002
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • CT State Medical License
    CT State Medical License 2010 - 2015
  • PA State Medical License
    PA State Medical License 1996 - 2004
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Microsatellitosis in Patients with Melanoma  
    Richard L White, Mark B Faries, Stanley P Leong, Andrew J Sinnamon, Dale Han, Jane L Messina, Barbara A Pockaj, Giorgos C Karakousis, Edmund K Bartlett, John T Vetto, ..., Annals of Surgical Oncology

Press Mentions

  • GSK Presents Positive Efficacy Data of Dostarlimab in Mismatch Repair-Deficient (dMMR) Solid Cancers at ASCO Gastrointestinal Cancers Symposium
    GSK Presents Positive Efficacy Data of Dostarlimab in Mismatch Repair-Deficient (dMMR) Solid Cancers at ASCO Gastrointestinal Cancers SymposiumDecember 13th, 2019
  • Elios Therapeutics Announced That a Personalized Vaccine Reduced the Risk of Melanoma Recurrence in Patients with Previously Treated Disease
    Elios Therapeutics Announced That a Personalized Vaccine Reduced the Risk of Melanoma Recurrence in Patients with Previously Treated DiseaseJuly 17th, 2019
  • Lymph-Node Dissection Increases Rates of Regional Disease Control
    Lymph-Node Dissection Increases Rates of Regional Disease ControlSeptember 1st, 2017
  • Join now to see all

Professional Memberships